
A PHARMACEUTICAL COMPANY
focused on the treatment of pain
ROXRO PHARMA, Inc. is a late-stage specialty pharmaceutical company developing hospital strength acute pain products for convenient use by patients in the home setting. The company is led by a seasoned management team that has successfully discovered, developed and commercialized several pain and cardiovascular medicines that are widely prescribed today.
February 06, 2009
ROXRO Announces FDA Accepts for Review NDA for Sprix (formerly ROX-888). for the Management of Acute Moderate to Severe Pain 

September 06, 2008
ROXRO PHARMA Presents Migraine Proof-of-Concept Data at the European Headache and Migraine Trust International Congress 2008 

May 05, 2008
ROXRO PHARMA’s Phase 3 Intranasal Analgesic Data Receives Excellence Award 
ROXRO is developing two products for the treatment of acute pain:



Overview
Milestones

